Pablo J Cagnoni Incyte Corp (INCY) insider trading activity

Pablo J Cagnoni is President, R&D of INCYTE CORP. Currently has a direct ownership of 217,262 shares of INCY, which is worth approximately $17 Million. The most recent transaction as insider was on Jul 15, 2025, when has been sold 2,628 shares (Common Stock) at a price of $68.25 per share, resulting in proceeds of $179,361. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 217K

1.77% 3M change

1.77% 12M change

Total Value Held $17 Million

PABLO J CAGNONI Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 15 2025	SELL Payment of exercise price or tax liability	$179,361 $68.25 p/Share	2,628 Reduced 1.2%	217,262 Common Stock
Jul 15 2025	BUY Grant, award, or other acquisition	-	17,538 Added 6.95%	234,800 Common Stock
Jul 14 2025	SELL Payment of exercise price or tax liability	$89,574 $69.98 p/Share	1,280 Reduced 0.58%	219,890 Common Stock
Jul 15 2024	SELL Payment of exercise price or tax liability	$48,123 $64.25 p/Share	749 Reduced 0.34%	221,170 Common Stock
Jul 15 2024	BUY Grant, award, or other acquisition	-	19,851 Added 8.21%	221,919 Common Stock
Jul 14 2023	BUY Grant, award, or other acquisition	-	9,668 Added 4.57%	202,068 Common Stock
Jun 05 2023	BUY Grant, award, or other acquisition	-	179,613 Added 50.0%	179,613 Common Stock

Also insider at

CRSP

CRISPR Therapeutics AG Healthcare

Director

RUBY

Rubius Therapeutics, Inc. Healthcare

Director

FUSN

Fusion Pharmaceuticals Inc. Healthcare

PJC

Pablo J Cagnoni

President, R&D

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INCY shares.

Notify only if

Value

Insider Trading

Get notified when an Incyte Corp insider buys or sells INCY shares.

Notify only if

Operation

Value

Type

News

Receive news related to INCYTE CORP

Track Activities on INCY

Account